Epclusa (sofosbuvir/velpatasvir) is a brand-name prescription medication. It’s approved by the Food and Drug Administration (FDA) to treat hepatitis C, which is an ...

Hepatitis C is one of the most common viral infections in the United States. Without treatment, hepatitis C can lead to severe health issues. Epclusa was approved to treat chronic hepatitis C by the ...

Sofosbuvir, velpatasvir; 150mg/37.5mg, 200mg/50mg; per packet. Sofosbuvir is an inhibitor of the HCV NS5B RNA-dependent RNA polymerase, which is required for viral replication. Sofosbuvir is a ...

If you have hepatitis C, your doctor may prescribe an antiviral medication, such as Mavyret (glecaprevir and pibrentasvir) or Epclusa (velpatasvir and sofosbuvir). Hepatitis C is an infection caused ...

Harvoni (ledipasvir/sofosbuvir) is a brand-name drug that’s prescribed for hepatitis C in adults and some children. Harvoni comes as oral tablets and pellets that ...

Credit: Getty Images. The expanded approval was based on data from an open-label phase 2 trial that evaluated Epclusa in 41 patients 3 years to less than 6 years of age with chronic HCV infection. The ...